Prevest Denpro Ltd.
| BSE: 543363 | Sector: Health care |
| NSE: N.A. | ISIN Code: INE0GAO01018 |
| BSE 13:18 | 07 Jul | 293.45 |
2.35 (0.81%) |
OPEN
298.95 |
HIGH
298.95 |
LOW
293.35 |
| NSE 05:30 | 01 Jan | Prevest Denpro Ltd |
| OPEN | 298.95 |
| PREVIOUS CLOSE | 291.10 |
| VOLUME | 3200 |
| 52-Week high | 478.15 |
| 52-Week low | 170.65 |
| P/E | 30.44 |
| Mkt Cap.(Rs cr) | 352 |
| Buy Price | 290.95 |
| Buy Qty | 400.00 |
| Sell Price | 296.90 |
| Sell Qty | 400.00 |
Prevest Denpro Ltd. (PREVESTDENPRO) - Net Sales
Market Cap
| COMPANY | LATEST(Rs) | CHG | CHG(%) | Net Sales (Rs crore) |
| Aurobindo Pharma | 546.00 | 2.20 | 0.40 | 15823.68 |
| Cipla | 939.30 | -6.55 | -0.69 | 13900.58 |
| Dr Reddy's Labs | 4351.65 | -42.15 | -0.96 | 13349.10 |
| Sun Pharma.Inds. | 846.40 | 8.70 | 1.04 | 12803.21 |
| Lupin | 632.15 | 2.05 | 0.33 | 11055.93 |
| Apollo Hospitals | 3873.95 | -8.45 | -0.22 | 9153.00 |
| Zydus Lifesci. | 366.80 | 0.85 | 0.23 | 7790.40 |
| Glenmark Pharma. | 390.10 | 1.20 | 0.31 | 7567.93 |
| Alkem Lab | 3099.50 | 17.75 | 0.58 | 7219.68 |
| Divi's Lab. | 3681.10 | 34.70 | 0.95 | 6798.61 |
| Torrent Pharma. | 2943.85 | 45.00 | 1.55 | 6742.32 |
| Ipca Labs. | 954.80 | 10.80 | 1.14 | 5114.11 |
| Alembic Pharma | 745.60 | 16.75 | 2.30 | 5051.44 |
| Laurus Labs | 491.80 | 23.00 | 4.91 | 4707.04 |
| Abbott India | 19241.00 | 51.15 | 0.27 | 4310.02 |
| Gland Pharma | 2590.00 | 15.45 | 0.60 | 3462.88 |
| Glaxosmi. Pharma | 1495.00 | -50.10 | -3.24 | 3217.51 |
| Granules India | 276.80 | 1.55 | 0.56 | 3134.98 |
| Sanofi India | 6487.60 | 1.80 | 0.03 | 2956.60 |
| Ajanta Pharma | 1186.40 | -4.55 | -0.38 | 2718.59 |
Quick Links for Prevest Denpro:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
